Search Page

1

Cite

Share

[Benfluorex (Mediator®), our vigilance in question].

Frachon I. Frachon I. Presse Med. 2011 May;40(5):459-61. doi: 10.1016/j.lpm.2011.02.019. Epub 2011 Apr 5. Presse Med. 2011. PMID: 21470816 French. No abstract available.

Cite

Share

2

Cite

Share

Update on the roles of distal airways in asthma.

Burgel PR, de Blic J, Chanez P, Delacourt C, Devillier P, Didier A, Dubus JC, Frachon I, Garcia G, Humbert M, Laurent F, Louis R, Magnan A, Mahut B, Perez T, Roche N, Tillie-Leblond I, Tunon de Lara M, Dusser D. Burgel PR, et al. Among authors: frachon i. Eur Respir Rev. 2009 Jun;18(112):80-95. doi: 10.1183/09059180.00001109. Eur Respir Rev. 2009. PMID: 20956128 Free article. Review.

Cite

Share

3

Cite

Share

[Diagnosis and care of postembolic pulmonary hypertension: the role of the pneumologist].

Frachon I, Jaïs X, Leroyer C, Jobic Y, Huchot E, Simonneau G, Dartevelle P. Frachon I, et al. Rev Pneumol Clin. 2008 Dec;64(6):316-24. doi: 10.1016/j.pneumo.2008.09.009. Epub 2008 Nov 26. Rev Pneumol Clin. 2008. PMID: 19084211 Review. French.

Cite

Share

4

Cite

Share

[About the settlement of litigations concerning the harm caused by benfluorex (Mediator®)].

Nicot P, Frachon I, Hill C. Nicot P, et al. Among authors: frachon i. Presse Med. 2013 Apr;42(4 Pt 1):411-8. doi: 10.1016/j.lpm.2013.02.310. Epub 2013 Mar 11. Presse Med. 2013. PMID: 23490638 Review. French.

Cite

Share

5

Cite

Share

[Treatments targeting distal airways in asthma: update on clinical studies].

Burgel PR, Frachon I, Didier A, Dusser D. Burgel PR, et al. Among authors: frachon i. Rev Mal Respir. 2009 Oct;26(8):859-66. doi: 10.1016/s0761-8425(09)73681-2. Rev Mal Respir. 2009. PMID: 19953030 Review. French.

Cite

Share

6

Cite

Share

Pulmonary hypertension associated with benfluorex exposure.

Savale L, Chaumais MC, Cottin V, Bergot E, Frachon I, Prevot G, Pison C, Dromer C, Poubeau P, Lamblin N, Habib G, Reynaud-Gaubert M, Bourdin A, Sanchez O, Tubert-Bitter P, Jaïs X, Montani D, Sitbon O, Simonneau G, Humbert M. Savale L, et al. Among authors: frachon i. Eur Respir J. 2012 Nov;40(5):1164-72. doi: 10.1183/09031936.00188611. Epub 2012 Apr 20. Eur Respir J. 2012. PMID: 22523367 Free article.

Cite

Share

7

Cite

Share

Amphetamine Derivatives and the Risk of Pulmonary Arterial Hypertension: A Missing Chapter of the Story?

Frachon I. Frachon I. Am J Respir Crit Care Med. 2018 May 15;197(10):1364. doi: 10.1164/rccm.201711-2319LE. Am J Respir Crit Care Med. 2018. PMID: 29272590 No abstract available.

Cite

Share

8

Cite

Share

Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases.

Couderc LJ, Stelianides S, Frachon I, Stern M, Epardeau B, Baumelou E, Caubarrere I, Hermine O. Couderc LJ, et al. Among authors: frachon i. Respir Med. 1999 Jan;93(1):65-8. doi: 10.1016/s0954-6111(99)90080-x. Respir Med. 1999. PMID: 10464852 Free article. Review. No abstract available.

Cite

Share

9

Cite

Share

Benfluorex withdrawal in France: Still be hiding somewhere in the world?

Frachon I, Le Gal G, Hill C, Leroyer C. Frachon I, et al. J Pharmacol Pharmacother. 2011 Oct;2(4):307-8. doi: 10.4103/0976-500X.85942. J Pharmacol Pharmacother. 2011. PMID: 22025868 Free PMC article. No abstract available.

Cite

Share

10

Cite

Share

Fenfluramine-like cardiovascular side-effects of benfluorex.

Boutet K, Frachon I, Jobic Y, Gut-Gobert C, Leroyer C, Carlhant-Kowalski D, Sitbon O, Simonneau G, Humbert M. Boutet K, et al. Among authors: frachon i. Eur Respir J. 2009 Mar;33(3):684-8. doi: 10.1183/09031936.00086308. Eur Respir J. 2009. PMID: 19251806 Free article.

Cite

Share